STAT's Adam Feurstein Tweets: 'There's an analyst named Hartaj Singh at Oppenheimer who just initiated on $CLSN and $SNSS w/ outperform ratings, $9 and $7 PTs, respectively. Poor guy. FHL.'
Celsion Announces Publication of the Study of ThermoDox® + Ultrasound, “TARDOX Study Protocol” in the Journal of Therapeutic Ultrasound
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.